Our observation that sulindac treatment diminishes the nuclear accumulation of the transcriptional coactivator β-catenin in adenomas of FAP patients in vivo strongly suggests that NSAIDs exert tumour suppressive effects by interfering with TCF-mediated transcription. The gene discussed is HNF4A; the disease is adenoma.